Navigation Links
U of M study: Monitoring cholesterol increases life expectancy

MINNEAPOLIS / ST. PAUL (June 8, 2010) A University of Minnesota study definitively shows that those with decreased LDL cholesterol levels can count on an increased life expectancy. The research is published in the May 24 edition of the Annals of Surgery.

The findings stem from the Program on Surgical Control of the Hyperlipidemias (POSCH) randomized controlled trial which kicked off at the University of Minnesota in 1975. Researchers evaluated 838 heart attack survivors between the ages of 38-60. Of the 838, 417 patients were assigned to treatment with diet instruction only, and 421 to diet instruction plus a partial ileal bypass surgery, or bypass of the distal small intestine where cholesterol is absorbed.

Twenty five years later, University of Minnesota Medical School researchers found the group who had surgery increased life expectancy by about one year.

"This study contributes to a long path of findings from the POSCH trial, that is, high levels of LDL cholesterol are detrimental to your health," said Henry Buchwald, M.D., Ph.D., bariatric surgeon at the University of Minnesota Medical School, and principal investigator of the study.

Through the years, and through a number of high-profile published journal studies, the POSCH study has repeatedly shown that reducing high LDL cholesterol means fewer heart attacks, fewer deaths, less incidence of peripheral artery disease, and less heart disease.

"The POSCH trial was the first randomized controlled trial to show the life-sustaining benefits of cholesterol lowering and it is the only trial with 25 years of follow-up," Buchwald said.

Because of the advent of statins, the surgery is now relegated to a small minority of patients who have adverse effects to drugs.


Contact: Kelly O'Connor
University of Minnesota

Page: 1

Related medicine news :

1. Study: Many physicians not using established criteria
2. New Study: Innovative Technique Allows Male Cancer Survivors Who are Sterile from Treatment to Father Children
3. IU study: Half of urban teen girls acquire STIs within 2 years of first sexual activity
4. McGill-CHUM study: 56 percent of young adults in a new sexual relationship infected with HPV
5. Study: Choice between stroke-prevention procedures influenced by patient age
6. UNC study: Obese 3-year-olds show early warning signs for future heart disease
7. New Study: Improved Immune System with Gene-Eden, a Natural Antiviral Supplement that Targets Chronic Viruses
8. Henry Ford Hospital study: Shoulder function not fully restored after surgery
9. Study: Federal funds support health depts., but leadership is key
10. Study: Kidney disease a big risk for younger, low-income minorities
11. Study: Mechanomyography to be accurate in detecting nerves during minimally invasive spine surgery
Post Your Comments:
(Date:12/1/2015)... ... , ... With FCPX Overlay: Grit , users can apply a grit ... are truly endless, all with a click of a mouse. Each user has full ... depth of field and more, all within Final Cut Pro X. , With FCPX ...
(Date:12/1/2015)... ... December 01, 2015 , ... SonaCare ... 2015 HSJ Acute Sector Innovation Award on November 18th. This prestigious award recognizes ... and propose exciting enhancements to the medical landscape. , The UCLH team won ...
(Date:11/30/2015)... ... 30, 2015 , ... Olympic Gold Medalists and Celebrity Moms ... across various categories through traditional and social media marketing campaigns and other branding ... Gold Medal Moms who can connect with today’s most important consumer: mothers. In ...
(Date:11/30/2015)... NY (PRWEB) , ... December 01, 2015 , ... ... honors Christina Colon as a 2015-2016 inductee into its VIP Woman ... in pharmacy. NAPW is the nation’s leading networking organization exclusively for professional women, ...
(Date:11/30/2015)... Los Angeles, California (PRWEB) , ... November 30, ... ... in all the programs of the19th Bi-National Convention of the Federation of Philippine ... Resort and Casino in Las Vegas, Nevada. , 1Heart Caregiver Services, as ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... BASEL, Switzerland , Dec. 1, 2015  Roche ... wholly-owned UK subsidiary Proximagen Ltd., today announced a worldwide ... small molecule inhibitor of Vascular Adhesion Protein 1 (VAP-1), ... treatment of inflammatory disease. The VAP-1 inhibitor is currently ... --> Under the terms of the ...
(Date:11/30/2015)... LOUIS , Dec. 1, 2015 Express Scripts ... Imprimis Pharmaceuticals (NASDAQ: IMMY ) to drive access to ... for the treatment of toxoplasmosis that has been recently priced ... others with weakened immune systems. --> ... of pyrimethamine and leucovorin (a form of folic acid) for $1 ...
(Date:11/30/2015)... Die MEDTEC Japan 2016, ... Entwicklung und Herstellung medizinischer Geräte, findet ... in Tokyo ... Foto: ... --> ...
Breaking Medicine Technology: